Travere Therapeutics, Inc., announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) ...

AI brainwave headbands, bone-building belts, blockchain pharma tracking, luxury smart rings. 10 innovations transforming how ...

A pharmacist has issued a warning about the potential risks of popular indigestion remedies like Gaviscon and Rennies if ...

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...

January is the perfect time to reset and nourish your body. Naturya’s superfood products make healthy living simple with ...

If you are a daily drinker you may feel a bit worse to start with while your body adjusts to not having alcohol in its system ...

Pharmcist Anum has issued a warning to people who regularly take over-the-counter medications, such as indigestion remedies.

LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration ...

Medical science can typically provide a clear explanation of the intricacies of the human body. However, there are times when ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...

U.S. FILSPARI reaches all-time highs of 908 new PSFs and net product sales of approximately $103 million in 4Q 2025Company ...

Biomarkers associated with cognitive impairment differ between men and women with chronic kidney disease, according to data ...